Page last updated: 2024-10-21

amitrole and Cancer of Prostate

amitrole has been researched along with Cancer of Prostate in 1 studies

Amitrole: A non-selective post-emergence, translocated herbicide. According to the Seventh Annual Report on Carcinogens (PB95-109781, 1994) this substance may reasonably be anticipated to be a carcinogen. (From Merck Index, 12th ed) It is an irreversible inhibitor of CATALASE, and thus impairs activity of peroxisomes.
amitrole : A member of the class of triazoles that is 1H-1,2,4-triazole substituted by an amino group at position 3. Used to control annual grasses and aquatic weeds (but not on food crops because it causes cancer in laboratory animals). Its use within the EU was banned from September 2017 on the grounds of potential groundwater contamination and risks to aquatic life; there have also been concerns about its endocrine-disrupting properties.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wagner, BA1
Evig, CB1
Reszka, KJ1
Buettner, GR1
Burns, CP1

Other Studies

1 other study available for amitrole and Cancer of Prostate

ArticleYear
Doxorubicin increases intracellular hydrogen peroxide in PC3 prostate cancer cells.
    Archives of biochemistry and biophysics, 2005, Aug-15, Volume: 440, Issue:2

    Topics: Amitrole; Antibiotics, Antineoplastic; Catalase; Dose-Response Relationship, Drug; Doxorubicin; Drug

2005